| # | Drug | Count |
|---|---|---|
| 0 | MINOCYCLINE | 138 |
| 1 | METHOTREXATE SODIUM | 86 |
| 2 | METHOTREXATE | 78 |
| 3 | PREDNISOLONE | 71 |
| 4 | PREDNISOLONE ORAL | 71 |
| 5 | PREDNISOLONE ORAL SOLUTION | 71 |
| 6 | ADALIMUMAB | 65 |
| 7 | INFLIXIMAB | 55 |
| 8 | AZATHIOPRINE | 53 |
| 9 | TOCILIZUMAB | 53 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ERYTHROMYCIN AND BENZOYL PEROXIDE | 8 | 0.0494 |
| 1 | MINOCYCLINE | 138 | 0.0118 |
| 2 | ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE | 1 | 0.0076 |
| 3 | MINOCYCLINE HYDROCHLORIDE | 35 | 0.0059 |
| 4 | ANAKINRA | 44 | 0.0026 |
| 5 | DROSPIRENONE AND ESTRADIOL | 1 | 0.0019 |
| 6 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 1 | 0.0016 |
| 7 | GARADACIMAB | 1 | 0.0013 |
| 8 | TRETINOIN | 8 | 0.0010 |
| 9 | ADALIMUMAB-FKJP | 34 | 0.0007 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-1 Receptor Antagonist [EPC] | 44 | 0.0026 |
| 1 | Purine Antimetabolite [EPC] | 53 | 0.0005 |
| 2 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 2 | 0.0004 |
| 3 | Interleukin-6 Receptor Antagonist [EPC] | 53 | 0.0004 |
| 4 | Alkaloid [EPC] | 10 | 0.0004 |
| 5 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 5 | 0.0002 |
| 6 | Alkylating Drug [EPC] | 54 | 0.0002 |
| 7 | CD52-directed Cytolytic Antibody [EPC] | 4 | 0.0002 |
| 8 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 9 | Sulfone [EPC] | 2 | 0.0002 |